A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. [electronic resource]
- Molecular endocrinology (Baltimore, Md.) Nov 2002
- 2628-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.